期刊文献+

白癜风患者血清巨噬细胞移动抑制因子和肿瘤坏死因子α的表达 被引量:6

Detection of macrophage migration inhibition factor and tumor necrosis factor-α in the sera of patients with vitiligo
原文传递
导出
摘要 目的探讨白癜风患者血清中巨噬细胞移动抑制因子(MIF)和肿瘤坏死因子α(TNF-α)水平的变化及临床意义。方法酶联免疫吸附试验和放射免疫法检测66例白癜风患者和30例健康对照血清MIF和TNF-α的表达。结果寻常型白癜风患者组和健康对照组血清MIF水平分别为(9.56±1.65)μg/L和(5.18+0.81)μg/L,TNF-α水平分别为(2.38±0.37)μg/L和(1.78±0.21)μg/L,寻常型白癜风患者组均显著高于健康对照组(P值均〈0.01)。寻常型白癜风患者血清MIF和TNF-α水平呈正相关(r=0.89,P〈0.05)。节段型白癜风患者组血清MIF和TNF-α水平与健康对照组比较,差异均无统计学意义(P〉0.05)。进展期白癜风患者血清MIF水平显著高于稳定期(P〈0.01)。结论MIF和TNF-α可能在白癜风的发病机制中起一定作用。MIF与寻常型白癜风的活动性可能有关。 Objective To determine the serum levels of macrophage migration inhibition factor (MIF) and tumor necrosis factor-or (TNF-α) in patients with vitiligo, and to investigate their clinical significance. Methods The serum concentrations of MIF and TNF-α were determined by enzyme linked immunosorbent assay (ELISA) and radioimmunoassay respectively in 66 patients with vitiligo and 30 healthy controls. Results The patients with vitiligo vulgaris showed a significant higher serum level of MIF and TNF-α compared with the healthy controls ((9.56 ± 1.65) vs.(5.18 ± 0.81) μg/L, (2.38 ± 0.37) vs.(1.78 ± 0.21) μg/L, both P 〈 0.01). There was a positive correlation between the serum level of MIF and TNF-α (r = 0.89, P 〈 0.05). No statistical difference was observed in the serum levels of MIF or TNF-α between the healthy controls and patients with segmental vitiligo (both P 〉 0.05). The serum level of MIF was significantly higher in patients with progressive vitiligo than in those with stable vitiligo (P 〈 0.01 ). Conclusions MIF and TNF-α might play a certain role in the pathogenesis of vitiligo, and MIF may be related to the activity of vitiligo vulgaris.
出处 《中华皮肤科杂志》 CAS CSCD 北大核心 2012年第9期673-674,共2页 Chinese Journal of Dermatology
基金 国家自然科学基金(30872272)
作者简介 通信作者:陶娟,Email:tjhappy@126.com
  • 相关文献

参考文献6

  • 1Rezaei N, Gavalas NG, Weetman AP, et al.Autoimmunity as an aetiologica| factor in vitiligo. J Eur Acad Dermatol Venereol, 2007, 21(7): 865-876.
  • 2Guerra L, Dellambra E, Brescia S, et al. Vitiligo: pathogenetic hypotheses and targets for current therapies. Curr Drug Metab, 2010, 11(5): 451-467.
  • 3Serarslan G, Yonden Z, Sogut S, et al. Macrophage migration inhibitory factor in patients with vitiligo and relationship between duration and clinical type of disease. Clin Exp Dermatol, 2010, 35 (5): 487-490.
  • 4Kim NH, Torchia D, Rouhani P, et al. Tumor necrosis factor-a in vitiligo: direct correlation between tissue levels and clinical parameters. Cutan Ocul Toxieol, 2011, 30(3 ): 225-227.
  • 5Lv Y, Li Q, Wang L, et al. Use of anti-tumor necrosis factor a- gents: a possible therapy for vitiligo. Med Hypotheses, 2009, 72 (5): 546-547.
  • 6Juttner S, Bernhagen J, Metz CN, et al. Migration inhibitory factor induces killing of Leishmania major by macrophages: dependence on reactive nitrogen intermediates and endogenous TNF-alpha. J Immunol, 1998, 161 (5): 2383-2390.

同被引文献47

  • 1Spritz RA.The genetics of generalized vitiligo [ J ]. Curr Dir Autoimmun, 2008,10(2) :2dd-257.
  • 2Harris JE, Harris TH, Weninger W, et al. A mouse model of vitiligo with focused epidermal depigmentation requires IFN-/for autoreactive CD8+ T-cell accumulation in the skin [ J ]. J Invest Dermatol, 2012, 132 ( 7 ) : 1869-1876.
  • 3Abraham LJ, Kroeger KM. Impact of the - 308 TNF promoter polymor- phism on the transcriptional regulation of the TNF gene: relevance to disease [ J ].J Leukoe Biol, 1999,66 (4) : 562-566.
  • 4Bingga G, Liu ZC, Zhang JF, et al. High resolution melting analysis (HRM) as a new tool for the identification of species belonging to the Laetobacillus case group and comparison with species-specific PCRs and multiplex PCR[ J]. Food Microbiol,2015,46(4) : 357-367.
  • 5Prajantasen T, Fueharoen S, Fucharoen G.High resolution melting ana- lytical platform for rapid prenatal and postnatal diagnosis of 13-thalasse- mia common among Southeast Asian population [ J]. Clin Chim Acta, 2015,441(2) : 56-62.
  • 6Singh M, Gupta VH, Amarapurkar DN, et al.Association of genetic va- riants with anti-tuberculosis drug induced hepatotoxicity: a high resolu- tion melting analysis [ J ]. Infect Genet Evol, 2014,23 ( 1 ) : 42-48.
  • 7Raymond L, Diebold B, Leroux C, et al. Validation of high-resolution DNA melting analysis for mutation scanning of the CDKL5 gene : identi- fication of novel mutations[ J]. Gene,2013,512( 1 ) : 70-75.
  • 8Badial PR, Oliveria-Filho JP, Winand NJ, et al. Allele frequency of hereditary equine regional dermal asthenia in American Quarter horses in Brazil determined by quantitative real-time PCR with high resolution meltin analvsis[J]. Vet .1.2014.199(2) , 306-307.
  • 9Mastoraki S, Chimonidou M, Dimitrakopoulos L, et al. A rapid and accurate closed-tube methylation-sensitive high resolution melting anal- ysis assay for the semi-quantitative determination of SOX17 promoter methylation in clinical samples [ J ]. Clin Chim Acta, 2015,444 ( 4 ) : 303-309.
  • 10Wittwer CT, Reed GH, Gundry CN, et al. High-resolution genotyping by amplicon melting analysis using LCGreen [ J ]. Clin Chem, 2003,49 (6 Pt 1) :853-860.

引证文献6

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部